Drawing for PHARMAESSENTIA

USPTO serial 99453069

PHARMAESSENTIA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BURCH, JILLIAN RENEE
Law office
TMO LAW OFFICE 128

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PHARMAESSENTIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Chainey Singleton

Chainey Singleton Singleton Law PLLC18383 Preston Road#202Dallas, TX 75252

Goods and services

ClassDescriptionStatusFirst use
035Advertising in the field of health care; marketing services in the field of health care; market analysis in the field of health care; data analysis in the field of health care; marketing research in the field of health care; advertising in the field of medical care; marketing services in the field of medical care; market analysis in the field of medical care; marketing research in the field of medical care; advertising in the field of oncology and/or autoimmune disease treatment; marketing services in the field of oncology and/or autoimmune disease treatment; market analysis in the field of oncology and/or autoimmune disease treatment; marketing research in the field of oncology and/or autoimmune disease treatment; advertising in the field of oncology treatment, particularly in the field of myeloproliferative neoplasms (MPNs); marketing services in the field of oncology treatment, particularly in the field of MPNs; market analysis in the field of oncology treatment, particularly in the field of MPNs; marketing research in the field of oncological treatment in the field of MPNs; organizing trade fairs in the field of health care in pharmaceutical industry; development of promotional campaigns in the pharmaceutical industry; arrangement and organization of business activities in the field of health care in pharmaceutical industry; business development in the field of health care in pharmaceutical industry; import and export in the field of pharmaceutical preparations; pharmaceutical retail store or wholesale store services; retail or wholesale services featuring pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 13, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 13, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 24, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2026DOCKASSIGNED TO EXAMINER—
Mar 5, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 5, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 20, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 20, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance